Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Jones

Showing results (341-350 of 463) with videos related to

Pageof 47
Sort By:
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletesM L Healy, J Gibney, C Pentecost, et al.
The British Journal of Dermatology|May 8, 1999
B-cell lymphoma associated with chronic lymphatic leukaemia: two cases with contrasting aggressive and indolent behaviourR C Ratnavel, D K Dunn-Walters, L Boursier, et al.
Cancer|December 18, 2001
Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndromeE A Fraser-Andrews, R Russell-Jones, A J Woolford, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 22, 2003
Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illnessPaul V Carroll, Nicola C Jackson, David L Russell-Jones, et al.
The British Journal of Dermatology|September 13, 2006
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoidesE A Fraser-Andrews, T Mitchell, S Ferreira, et al.
Diabetologia|August 27, 2009
Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetesF Smeeton, F Shojaee Moradie, R H Jones, et al.
The British Journal of Dermatology|February 19, 2009
Bexarotene therapy for mycosis fungoides and Sézary syndromeR A Abbott, S J Whittaker, S L Morris, et al.
Diabetes, Obesity & Metabolism|January 10, 2018
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trialChantal Mathieu, Bruce W Bode, Edward Franek, et al.
The British Journal of Dermatology|March 26, 2003
Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patientsS R Hoque, F J Child, S J Whittaker, et al.
Pageof 47

Showing results (341-350 of 463) with videos related to

Sort By:
Pageof 47
The Lancet. Diabetes & Endocrinology|March 14, 2014
Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trialsBernard Zinman, J Hans DeVries, Bruce Bode, et al.
The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletesM L Healy, J Gibney, C Pentecost, et al.
The British Journal of Dermatology|May 8, 1999
B-cell lymphoma associated with chronic lymphatic leukaemia: two cases with contrasting aggressive and indolent behaviourR C Ratnavel, D K Dunn-Walters, L Boursier, et al.
Cancer|December 18, 2001
Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndromeE A Fraser-Andrews, R Russell-Jones, A J Woolford, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 22, 2003
Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illnessPaul V Carroll, Nicola C Jackson, David L Russell-Jones, et al.
The British Journal of Dermatology|September 13, 2006
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoidesE A Fraser-Andrews, T Mitchell, S Ferreira, et al.
Diabetologia|August 27, 2009
Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetesF Smeeton, F Shojaee Moradie, R H Jones, et al.
The British Journal of Dermatology|February 19, 2009
Bexarotene therapy for mycosis fungoides and Sézary syndromeR A Abbott, S J Whittaker, S L Morris, et al.
Diabetes, Obesity & Metabolism|January 10, 2018
Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trialChantal Mathieu, Bruce W Bode, Edward Franek, et al.
The British Journal of Dermatology|March 26, 2003
Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patientsS R Hoque, F J Child, S J Whittaker, et al.
Pageof 47